Skip to main content

Natura Professional Division

THE HERBAL PROTOCOL

Vitex agnus-castus: Reframing a classic herb through a modern neuroendocrine lens

For most practitioners, Vitex agnus-castus L. (syn. chaste tree, chaste berry, monk’s pepper) is synonymous with “women’s hormone support.” In Western herbal medicine it is probably the most widely used herb for issues related to the female reproductive tract and hormone system [1,2,3].

However, a closer look at the pharmacology and emerging clinical evidence reveals something far more interesting: a neuroendocrine modulator with implications that extend beyond the menstrual cycle, beyond the reproductive years, and even beyond female physiology.


A Brief History of Medicinal Use

The medicinal use of V. agnus-castus dates back centuries. Early references to its value for “diseases of the uterus,” reduced libido and lactation after childbirth appear in the works of Hippocrates (460–375 BCE), Theophrastus and Dioscorides [2,3,4].

Historical uses include:

  • Dioscorides (40–90 CE): to bring on menses, promote lactation and aid sleep, and also for insanity, madness and epilepsy
  • Pliny the Elder (23–79 CE): to promote menstruation and lactation in breastfeeding women [5]
  • Gerard (1545–1612): for inflammation of the uterus and as an emmenagogue

These early indications align well with its modern gynaecological applications. Its use for menopausal symptoms only appeared in the 1970s [3].


Vitex agnus-castus as a Neuroendocrine Modulator

The effects of V. agnus-castus on the menstrual cycle were initially ascribed to “indirectly progestogenic” or “oestrogen modulating” actions. Current research focuses instead on upstream neuroendocrine mechanisms:

  • Dopaminergic activity
  • Prolactin regulation
  • Opioid receptor affinity
  • Melatonin modulation

Dopaminergic Activity & Prolactin Regulation

How Prolactin Is Regulated

Prolactin (PRL) is central to reproductive health, menstrual cycle regulation, conception and lactation. It is secreted by lactotroph cells in the anterior pituitary and tightly regulated by dopamine.

Dopamine binds to D2 receptors (D2R) on these cells, suppressing PRL synthesis and release. Disruption in dopamine secretion or receptor sensitivity can lead to elevated PRL (hyperprolactinaemia).

In turn, high PRL may impair dopaminergic signalling, contributing to mood disturbances and depressive symptoms [6,7,8]. In chronic hyperprolactinaemia, the negative feedback loop is disrupted, dopamine secretion falls and its inhibitory effect on PRL is lost [7].

Latent Hyperprolactinaemia

Mild or latent hyperprolactinaemia may arise during periods of declining oestradiol and progesterone or under physiological stress, and may be accompanied by corpus luteum insufficiency.

In the latent form, PRL is normal at baseline but spikes under stress or in the late luteal phase, often evading detection in routine blood tests [3,8].

Elevated PRL suppresses GnRH from the hypothalamus, reducing FSH and LH output and potentially impairing ovulation and fertility [6].

Thyroid Function and Mastalgia

Women with clinical or subclinical hypothyroidism often have mastalgia due to hyperprolactinaemia. The hypothalamus tries to stimulate thyroid function by releasing more thyrotropin-releasing hormone (TRH), which also stimulates prolactin release [9].

Prolactin and Autoimmunity

PRL stimulates the immune system and inhibits the “negative selection” of autoreactive B lymphocytes, thereby promoting autoimmunity. Hyperprolactinaemia is a triggering factor for autoimmune conditions and a predictor of disease activity and severity.

  • Hyperprolactinaemia occurs in an estimated 15–33% of patients with systemic lupus erythematosus (SLE), and PRL levels correlate directly with disease activity
  • Patients with rheumatoid arthritis (RA) show elevated PRL in blood and synovial fluid
  • It has also been linked to coeliac disease, systemic sclerosis, Graves’ disease, Hashimoto’s thyroiditis and multiple sclerosis [2,10]

How Vitex Acts on Prolactin

V. agnus-castus contains essential oils, flavonoids, iridoid glycosides and diterpenes. The diterpenes activate dopamine D2 receptors in the anterior pituitary, thereby inhibiting PRL release [3,8,9].

This is relevant to the conditions it is traditionally used for, all of which may involve latent hyperprolactinaemia [8]:

  • Premenstrual syndrome (PMS)
  • Cyclical mastalgia
  • Menstrual irregularities
  • Corpus luteum insufficiency
  • Infertility
  • Dysfunctional uterine bleeding
  • Mood instability
  • Menopausal symptoms

Dopamine also plays a key role in thermoregulation, mood, motivation and circadian rhythm, all relevant to perimenopausal symptom management [3].


Opioid Receptor Affinity

The opioid system, including endorphins, plays an essential role in:

  • Pain perception
  • Mood and appetite
  • HPA axis activity
  • The menstrual cycle and female sex hormones
  • Diuresis and water retention [11]

In women, increased stress raises endogenous opioid levels, causing PRL to rise and GnRH, FSH and LH to fall, eventually leading to anovulation [12].

Endorphins decrease during the luteal phase, contributing to PMS symptoms such as water retention, migraines and mood changes. A similar reduction is seen in menopause and is thought to be partly responsible for the central noradrenergic instability behind hot flushes.

Active constituents in V. agnus-castus have an affinity for opioid receptors and can influence opioid receptor binding, making it useful for easing PMS and menopausal symptoms [3,11].


Melatonin Modulation

Melatonin secretion is affected by sleep disorders, jet lag and shift work, and varies across the menstrual cycle and with the onset of menopause. Dysregulated melatonin, PRL and cortisol secretion is one of the factors implicated in PMS and mood disorders. Melatonin levels, and the time they remain elevated at night, both decrease with age, affecting sleep duration and quality [3,5,13].

Vitex and Nocturnal Melatonin

V. agnus-castus increases nocturnal melatonin secretion in a dose-dependent manner. In a double-blind, placebo-controlled study of 20 healthy males, 120–480 mg increased night-time melatonin output by 60% compared to placebo [5,13].

This has clinical implications for:

  • Improving sleep quality
  • Stabilising circadian rhythms
  • Alleviating sleeplessness in menopause (melatonin decline precedes the rise in FSH)
  • Supporting sleep in elderly men and women
  • Improving stress-related insomnia in men and women

This shows the potential of V. agnus-castus beyond female reproductive health [3].


Bone Health & Fracture Healing

A few studies have explored V. agnus-castus in bone health and fracture healing. Most are still at the animal and laboratory stage, but they show promise.

Osteoporosis Model in Rats

Sixty rats with induced osteoporosis were treated for 12 weeks with V. agnus-castus, oestradiol, testosterone or soy-free food. Compared with oestradiol supplementation, the V. agnus-castus group reached:

  • 87% of biomechanical values
  • 88.4% of trabecular bone area
  • 80.7% of trabecular number
  • 66.9% of trabecular nodes

The researchers concluded that V. agnus-castus had osteoprotective effects and might be a safe alternative to conventional hormone replacement therapy (HRT) [14].

Fracture Healing in Women

In a double-blind, randomised, placebo-controlled trial, 64 women with long bone fractures took one of four daily treatments for 8 weeks:

  • Chaste tree tablet (4 mg dried fruit extract) with 250 mg magnesium oxide (n = 10)
  • Chaste tree tablet with placebo (n = 15)
  • Placebo with 250 mg magnesium oxide (n = 12)
  • Placebo with placebo (n = 14)

Combining V. agnus-castus with magnesium increased serum osteogenic and angiogenic factors and callus formation, with a positive effect on fracture healing [15].


Conclusion

Viewed through a modern neuroendocrine lens, Vitex agnus-castus is far more than a traditional “female hormone herb.” Its dopaminergic actions, prolactin-modulating effects, opioid receptor interactions and influence on melatonin secretion show a plant that interfaces with core regulatory hubs of the neuroendocrine system.

Research supports its role in:

  • PMS and cyclical mastalgia
  • Perimenopausal symptoms
  • Sleep disturbances
  • Stress-related dysregulation
  • Bone metabolism and fracture healing
  • Autoimmune conditions

By shifting the focus from downstream sex hormone effects to these broader neuroendocrine pathways, V. agnus-castus can be understood as a versatile modulator relevant across ages, sexes and clinical contexts. This reframing deepens our understanding of its traditional uses and expands its potential applications in clinical practice well beyond female reproductive health.


References

  1. Wood M (2008) The Earthwise Herbal – Volume I
  2. Bone K & Mills S (2013) Principles and Practice of Phytotherapy
  3. Van Die et al. (2009) J Altern Complement Med 15(8):853-862
  4. Kamal et al. (2022) Plants 11(15):1944
  5. DiPasquale R (2010) Insights into Vitex agnus-castus, Past and Present, NDNR
  6. Al-Chalabi et al. (2023) Physiology: Prolactin, StatPearls
  7. Kadiri et al. (2025) Endocr Metab Immune Disord Drug Targets
  8. Puglia et al. (2023) Front Endocrinol 14:1269781
  9. Seidlova-Wuttke & Wuttke (2017) Clin Phytosci 3:6
  10. Borba et al. (2018) Front Immunol 9:73
  11. Webster et al. (2011) Biochem Pharmacol 81(1):170-177
  12. Böttcher et al. (2017) Fertil Steril 108(2):207-213
  13. Dericks-Tan et al. (2003) Exp Clin Endocrinol Diabetes 111(1):44-46
  14. Sehmisch et al. (2009) Phytother Res 23(6):851-858
  15. Eftekhari et al. (2014) J Res Med Sci 19(1):1-7

Leave feedback about this

0 Item | R0.00
View Cart